3651 results for «384»

Filter By

3651 results

TAVI: how to prevent stroke

17 May 2024 – From EuroPCR 2024

This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.

TAVI: how to prevent stroke

Transcatheter solutions for combined valve disease

17 May 2024 – From EuroPCR 2024

This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...

Transcatheter solutions for combined valve disease

Non left main bifurcation - LIVE case

17 May 2024 – From EuroPCR 2024

A 53-year-old male presented with a late STEMI one month ago. Coronary angiography revealed three-vessel disease: CX occlusion (culprit lesion), RCA bifurcation stenosis, and severe mid LAD-D1 (1-1-1) stenosis. The operators performed RCA PCI during the STEMI hospitalization.
In this live case, they performed the LAD-D1 bifurcation...

Non left main bifurcation - LIVE case

Hot topics in interventional management of out-of-hospital cardiac arrest (OHCA)

17 May 2024 – From EuroPCR 2024

This session explores the latest insights and strategies for managing out-of-hospital cardiac arrest (OHCA) patients. Key topics include identifying OHCA patients who may benefit from immediate cathlab admission, the default PCI strategy in OHCA, and how to organize an effective OHCA network. Discussions will cover estimating...

Hot topics in interventional management of out-of-hospital cardiac arrest (OHCA)

EAPCI Fellowship Grants Award Ceremony

16 May 2024 – From EuroPCR 2024

This session is the EAPCI Fellowship Grants Award Ceremony, where outstanding individuals will be recognized for their contributions to the field of interventional cardiology.

EAPCI Fellowship Grants Award Ceremony

New evidence on TAVI from PCR Companions

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...

New evidence on TAVI from PCR Companions

Andreas Grüntzig Ethica Award ceremony

15 May 2024 – From EuroPCR 2024

This session is the Andreas Grüntzig Ethica Award ceremony.

Andreas Grüntzig Ethica Award ceremony

Imaging and physiology guided PCI

17 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 clinical case submissions showcasing the use of imaging and physiology guidance during PCI. Cases cover topics such as managing cardiac arrest during PCI, virtual reality-guided PCI, low-contrast PCI in multivessel disease, and the comprehensive assessment of obstructive and non-obstructive coronary...

Imaging and physiology guided PCI

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial

Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial

03 Sep 2025

Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Alessandro Sticchi

Author

Alessandro Sticchi
OPINION Trial: 1-year outcomes

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
Didn’t find what you were looking for?